Imaging endogenous dopamine competition with [11C]raclopride in the human brain
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
This study images dopamine release in response to a neurochemically specific challenge with the psychostimulant drug methylphenidate. Changes in synaptic dopamine induced by methylphenidate were evaluated with positron emission tomography and [11 C]raclopride, a D 2 receptor radioligand that is sensitive to endogenous dopamine. Methylphenidate significantly decreased striatal [11 C]raclopride binding. The decrease was variable and was negatively correlated with age. Mood and anxiety at baseline, were also correlated with methylphenidate‐induced DA changes. This strategy provides a tool to investigate the responsiveness of the dopamine system in the normal and diseased human brain and to investigate the neurochemical correlates of behavior. © 1994 Wiley‐Liss, Inc.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Neurogenetic Adaptive Mechanisms in Alcoholism
Cloninger, C. R. (1987) · Science · doi:10.1126/science.2882604 · Cited by 2,234
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070 · cited 1×
“Dopamine (DA) is a neurotransmitter that plays a major role in movement, motivation, and reward (Koob and Bloom, 1988; Le Moal and Simon, 1991; Ritz et al., 1987; Wise, 1988).”
BackgroundAntipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622
Aromatic Amino Acids and Modification of Parkinsonism
Cotzias, G. C., Van Woert, M. H., & Schiffer, L. M. (1967) · New England Journal of Medicine · doi:10.1056/nejm196702162760703 · Cited by 1,494
Logan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., Hitzemann, R., Bendriem, B., Gatley, S. J., et al. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.127 · Cited by 1,479
Self-citationDOPAMINE (3-HYDROXYTYRAMINE) AND BRAIN FUNCTION
HORNYKIEWICZ, O. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07154-6 · Cited by 1,442
Factors That Predict Individual Vulnerability to Amphetamine Self-Administration
Piazza, P. V., Deminière, J.-M., Le Moal, M., & Simon, H. (1989) · Science · doi:10.1126/science.2781295 · Cited by 1,351
Research works printed but not linked: 9
- Davis K. L., 1991, Dopamine in schizophrenia: a review and reconceptualization. Am. J, Psychiatry, 148, 1474
- Ekman G., 1967, The measurement of subjective reactions, Forsvarsedicine, 33, 27
- Ferris R., 1972, A comparison of the capabilities of isomers of amphetamine, deoxyperadrol and methylphenidate to inhibit the uptake of catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta, J. Pharmacol., 14, 47
- Innis R. B., 1993, SPECT imaging demonstrates loss of striatal dopamine transporters in parkinson's disease, J. Nucl. Med., 34, 31
- Joseph J. A., 1990, The striatum, a microcosm for the examination of age‐related alterations in the CNS: a selected review. Rev. Biolog. Res, Aging, 4, 181
- Kandel D. B., 1989, Cessation of illicit drug use in young adulthood. Arch. Gen, Psychiatry, 46, 109
- Logan J., 1993, The effects of changes in blood flow on the distribution volume of [11C]raclopride binding, J. Nucl. Med., 34, 200
- Raichle M. E., 1983, Brain blood flow measured with intravenous H2 15O, J. Nucl. Med., 24, 790
- Wong D. F., 1992, C‐11 WIN 35,428 imaging of the dopamine transporter site in living human brain, J. Nucl. Med., 33, 964
Cited by
Items 301–379 of 379
Mann, L. G., Servant, M., Hay, K. R., Song, A. K., Trujillo, P., Yan, B., Kang, H., Zald, D. H., Donahue, M. J., Logan, G. D., et al. (2023) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_02048 · Cited by 8
“…dopamine levels also impact dopamine binding potential values, as stimulants, such as methylphenidate or amphetamine, increase synaptic dopamine concentration and consequently decrease receptor availability measured with [ 18 F]fallypride (Laruelle et al., 1995, 1997; Volkow et al., 1994).”
The search for consistency in the manufacture of PET radiopharmaceuticals
Finn, R. D. (1999) · Annals of Nuclear Medicine · doi:10.1007/bf03164930 · Cited by 8
Kubota, M., Kimura, Y., Shimojo, M., Takado, Y., Duarte, J. M. N., Takuwa, H., Seki, C., Shimada, H., Shinotoh, H., Takahata, K., et al. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211004150 · Cited by 10
Influence of Motor Activity on Striatal Dopamine Release: A Study Using Iodobenzamide and SPECT
Larisch, R., Schommartz, B., Vosberg, H., & Müller-Gärtner, H.-W. (1999) · NeuroImage · doi:10.1006/nimg.1999.0461 · Cited by 8
Wong, D. F., SØLLING, T., Yokoi, F., & GJEDDE, A. H. (1998) · Elsevier eBooks · doi:10.1016/b978-012161340-2/50071-8 · Cited by 9
de Beer, F., de Vries, E. F. J., Wijnen, B. F. M., Begemann, M., van Beveren, N. J. M., Boonstra, N., Gangadin, S. S., de Haan, L., Hamers, I. M. H., Veling, W., et al. (2025) · Psychological Medicine · doi:10.1017/s003329172510161x · Cited by 8
Biological Underpinning of Behavioral Addictions and Management Implications
Yau, Y. H. C., Leeman, R. F., & Potenza, M. N. (2020) · Springer eBooks · doi:10.1007/978-3-030-36391-8_63 · Cited by 8
Age-related differences in striatal dopamine D1 receptors mediate subjective drug effects
Manza, P., Kojori, E. S., Demiral, Ş. B., Zhang, R., Dennis, E., Johnson, A., Vines, L., Sotelo, D., Tomasi, D. G., Wang, G., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci164799 · Cited by 7
“scans were conducted on two separate days: once 1h after administration of an oral placebo pill and once 1h after administration of 60 mg oral MP, to quantify “dopamine increases” by comparing changes in D2R availability with placebo scans (6).”
MethodSelf-citationAlexoff, D. L., Vaska, P., & Logan, J. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)85012-2 · Cited by 7
Self-citationPET y SPECT de neurotransmisión cerebral
DOĞAN, A. S., & Catafau, A. (2003) · Revista Española de Medicina Nuclear · doi:10.1016/s0212-6982(03)72158-2 · Cited by 9
Schlösser, R. G. M. (2000) · Der Nervenarzt · doi:10.1007/s001150050002 · Cited by 7
Neuroimaging bei Substanzabhängigkeit
de Mendelssohn, A., Kasper, S. F., & Tauscher, J. T. (2004) · Der Nervenarzt · doi:10.1007/s00115-003-1565-7 · Cited by 8
Radiosynthesis of (N-[11C]methyl)benperidol for PET investigation of D2 receptor binding
Moerlein, S. M., Perlmutter, J. S., & Welch, M. J. (2004) · Radiochimica Acta · doi:10.1524/ract.92.4.333.35584 · Cited by 6
The neurochemistry of therapeutics: Levodopa pharmacodynamics in Parkinson's disease
Frey, K. A. (2001) · Annals of Neurology · doi:10.1002/ana.62 · Cited by 6
McClure, S. M., & D’Ardenne, K. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374620-7.00010-8 · Cited by 5
“However, PET offers the ability to target specific neurotransmitter systems, including dopamine [60] .”
BackgroundIkoma, Y., Takuwa, H., Nishino, A., Maeda, J., Kawamura, K., Obata, T., Zhang, M., Higuchi, M., & Suhara, T. (2021) · Annals of Nuclear Medicine · doi:10.1007/s12149-021-01633-4 · Cited by 5
Jeong, J.-E., Paik, S.-H., Choi, M., Cho, H., Choi, J., Choi, S., & Kim, D. (2019) · Psychiatry Investigation · doi:10.30773/pi.2019.04.02.2 · Cited by 5
Sethi, S. K., Varshney, R., Rangaswamy, S., Chadha, N., Hazari, P. P., Kaul, A., Chuttani, K., Milton, M. D., & Mishra, A. K. (2014) · RSC Advances · doi:10.1039/c4ra07004f · Cited by 5
Fowler, J. S., Wang, G. J., Volkow, N. D., Ieni, J. R., Logan, J., Pappas, N. R., & Dewey, S. L. (1999) · Clinical Positron Imaging · doi:10.1016/s1095-0397(99)00028-x · Cited by 7
Self-citationCigarettes labeled with [11C]nicotine: formulation and administration for PET inhalation
Apana, S. M., & Berridge, M. S. (2009) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.1692 · Cited by 5
Neuroimaging and mechanisms of drug abuse: interface of molecular imaging and molecular genetics
Ernst, M., Kimes, A. S., & Jazbec, S. (2003) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(03)00109-6 · Cited by 5
Peñuelas, I. (2001) · Revista Española de Medicina Nuclear · doi:10.1016/s0212-6982(01)71997-0 · Cited by 6
Structural and Functional Neuroimaging of the Effects of Cocaine in Human and Nonhuman Primates
Porrino, L. J., Huston-Lyons, D., Letchworth, S. R., Freedland, C. S., & Nader, M. A. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-165-7_16 · Cited by 5
Exercise against cocaine sensitization in mice: a [18F]fallypride micro-PET study
Becker, G., Lespine, L., Bahri, M. A., Navacerrada, M. E. S., Lemaire, C. F., Luxen, A., Tirelli, E., & Plenevaux, A. (2021) · Brain Communications · doi:10.1093/braincomms/fcab294 · Cited by 4
Jimenez, H. T., Carrión, J., Adrien, L. R., Wolin, A., Eun, J. D., Cinamon, E., Chang, E. H., Davies, P., Vo, A., & Koppel, J. L. (2023) · Biomedicines · doi:10.3390/biomedicines11082091 · Cited by 4
“Image Acquisition MicroPET imaging with [11C] raclopride was performed to estimate striatal dopamine availability via D2R occupancy [67].”
MethodPET Imaging of Myocardial β-Adrenergic Receptors with Fluorocarazolol
Salinas, C. A., Muzic, R. F., Berridge, M. S., & Ernsberger, P. R. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000171754.51187.a6 · Cited by 4
Asth, L., Tiago, P. R. F., Costa, L. R. F., Holanda, V. A. D., Pacifico, S., Zaveri, N. T., Calò, G., Ruzza, C., & Gavioli, E. C. (2020) · Neuropeptides · doi:10.1016/j.npep.2020.102059 · Cited by 4
Biological Underpinning of Behavioural Addictions and Management Implications
Yau, Y. H. C., Leeman, R. F., & Potenza, M. N. (2014) · Springer eBooks · doi:10.1007/978-88-470-5322-9_71 · Cited by 6
Laruelle, M. A., Abi‐Dargham, A., & Innis, R. B. (1998) · Elsevier eBooks · doi:10.1016/b978-012161340-2/50070-6 · Cited by 4
The Non-Anhydrous, Minimally Basic Synthesis of the Dopamine D2 Agonist [18F]MCL-524
Inkster, J. A. H., Sromek, A. W., Akurathi, V., Neumeyer, J. L., & Packard, A. B. (2021) · Chemistry · doi:10.3390/chemistry3030075 · Cited by 3
Eleventh international symposium on radiopharmaceutical chemistry: Abstracts
(1995) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.2580370101 · Cited by 3
Neuroimaging Studies of Human Drug Addiction
Lawrence, N., & Stein, E. A. (2003) · CRC Press eBooks · doi:10.3109/9780203508343-5 · Cited by 3
Positron Emission Tomography in Parkinson’s Disease
Troiano, A. R., & Stoessl, A. J. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-888-5_3 · Cited by 3
Stenfors, C., & Ross, S. B. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100100465 · Cited by 3
New concepts and tools in imaging for the study of neurodegenerative disease
Stoessl, A. J., Lee, C. S., & de la Fuente‐Fernández, R. (2003) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-0643-3_9 · Cited by 3
Trajectories of late-life depression: insights from molecular imaging
Holmes, S. E., & Smith, G. S. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02340-2 · Cited by 2
Ikoma, Y., Kimura, Y., Yamada, M., Obata, T., Suhara, T., & Ito, H. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.811136 · Cited by 2
Weidner, L. D., Paris, A., Frankle, W. G., & Narendran, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140647 · Cited by 2
Neurochemical Mechanisms Underlying Responses to Psychostimulants
Volkow, N. D., Fowler, J. S., HITZEMANN, R. J., & Wang, G. (1996) · PsycEXTRA Dataset · doi:10.1037/e495692006-025 · Cited by 3
Self-citationImaging Studies in Substance Abuse
Volkow, N. D., Fowler, J. S., Wang, G., & Shreeve, W. W. (2003) · Springer eBooks · doi:10.1007/978-3-642-55539-8_18 · Cited by 2
Self-citationSchlösser, R. G. M., & Brodie, J. D. (2001) · Springer eBooks · doi:10.1007/978-3-642-59519-6_11 · Cited by 2
Human dopamine systems in addiction disorders
Volkow, N. D., & Manza, P. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-29867-7.00029-3 · Cited by 1
Self-citationPossible association between Toxoplasma gondii infection and autism spectrum disorder
Galeh, T. M., Nayeri, T., Dodangeh, S., Hosseininejad, Z., Tanzif, A., Khalilian, A., & Daryani, A. (2025) · Parasites Hosts and Diseases · doi:10.3347/phd.24066 · Cited by 1
“Dopamine is a neurotransmitter that plays a central role in reward-motivated behavior and motor control, and its dysfunction has been implicated in various neurological and psychiatric disorders [70].”
Eklund, M. R. E., Hassanain, E., Vahlberg, T., Joutsa, J., & Kaasinen, V. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03826-7 · Cited by 1
In vivo imaging of dopamine and serotonin release: response to psychopharmacological challenges
de Haes, J. I. U. (2000) · Cited by 1
Neuronale Veränderungen bei Computerspielsucht
Breiner, T. C., & Kolibius, L. D. (2019) · Springer eBooks · doi:10.1007/978-3-662-57860-5_8 · Cited by 1
PET studies of the dopamine system in relation to cognitive functions
Erixon-Lindroth, N. (2007) · Figshare · Cited by 1
Positron emission tomography (PET) neurochemistry: where are we now and where are we going?
Grasby, P. M. (2003) · Cambridge University Press eBooks · doi:10.1017/cbo9780511550072.010 · Cited by 1
Assessment of Graft Effects and Function in Cell Replacement Therapy for Parkinson's Disease
Hagell, P. (2002) · Lund University Publications (Lund University) · Cited by 1
PET studies in Neuropharmacology
Brooks, D. J. (1998) · Springer eBooks · doi:10.1007/978-94-011-4996-9_20
Telang, F., & Vblkow, N. D. (2000) · Elsevier eBooks · doi:10.1016/b978-012481460-8/50025-1
Positron Emission Tomography Imaging
DHAWAN, V. M., & Eidelberg, D. (2009) · Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences · doi:10.1159/000209501
Individual Variation in the Motivational Properties of Reward Cues.
Saunders, B. T. (2013) · Deep Blue (University of Michigan)
Cunningham, V. J., & Welch, A. E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-444-53632-7.00116-7
Smith, G. S. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14050638
Studies of the Brain Cannabinoid System Using Positron and Single-Photon Emission Tomography
Gatley, S. J., Volkow, N. D., & Makriyannis, A. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9_17
Self-citationKoochesfahani, K. M. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0091744
“[C]raclopride is a specific D2-like receptor antagonist whose binding is subject to competition from endogenous dopamine (Seeman et al., 1989; Volkow et al., 1994).”
BackgroundImaging of Neurochemical Transmission in the Central Nervous System
Deuitch, L., & Narendran, R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418677-4.00019-1
Functional positron emission tomography in psychiatry
Grasby, P. M. (2012) · doi:10.1093/med/9780199696758.003.0023
Molecular imaging of major depression
Sacher, J., & Smith, G. S. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511782091.012 · Cited by 1
Endres, C. J., & Carson, R. E. (1998) · Elsevier eBooks · doi:10.1016/b978-012161340-2/50067-6
Fonteneau, C. (2018) · theses.fr (ABES) · doi:10.70675/b06abc42zba9az4c0bz8cbfzef0dd775e14e · Cited by 1
Patterns of Overeating that Characterize Addictive Tendencies towards Palatable Foods
Bonder, R. (2018) · YorkSpace (York University)
Böning, J., Kienast, T., Heinz, A., Lesch, O., Soyka, M., Wiesbeck, G. A., Böning, J., Wodarz, N., Platz, W. E., Scherbaum, N., et al. (2007) · Springer eBooks · doi:10.1007/3-211-37774-3_4 · Cited by 1
Bosker, F. J., Doorduin, J., Jongsma, M. E., Visser, A. K. D., de Haes, J. U., Cremers, T. I. F. H., Rea, K., Tyacke, R. J., Nutt, D. J., den Boer, J. A., et al. (2014) · Springer eBooks · doi:10.1007/978-3-642-40384-2_3
(2010) · Wiley eBooks · doi:10.1002/9781444328172.refs
Schlösser, R. G. M., & Brodie, J. D. (1999) · Springer eBooks · doi:10.1007/978-3-642-60174-3_11
Imaging Studies in Substance Abuse
Volkow, N. D., Fowler, J. S., & Wang, G. (2001) · Springer eBooks · doi:10.1007/978-3-642-59519-6_138
Self-citationThe hidden cost of free games: how microtransactions in mobile games impact players with ADHD
Griffin, J., & Reeve, C. (2025) · Popular Communication · doi:10.1080/15405702.2025.2598253
“Meanwhile, studies have linked video games to the release of dopamine, and furthermore, suggested that video games may cause a similar chemical reaction in players’ brains such as that created by stimulant drugs like methylphenidate (Koepp et al., 1998; Volkow et al., 1994; Weinstein, 2010).”
Bikas, S. (2025) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.95116
Bildgebende Forschung bei Drogenmißbrauch
Volkow, N. D., Fowler, J. S., & Wang, G. (2000) · Springer eBooks · doi:10.1007/978-3-642-59627-8_22
Self-citationEffects of methylphenidate on quantitative measures of motor function: a systematic review
Riis, K., Brittain, A. R., DadeMatthews, A. O., Watson, C. L., Grabowsky, A. B., & Neely, K. A. (2026) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2026.1756629
Développement préclinique et clinique du [18F]F13640 pour l'imagerie des récepteurs 5-HT1A cérébraux
Colom, M. (2020) · theses.fr (ABES) · doi:10.70675/434f5a8bz8c8ez4bf4z979czc7fa7eb94950
Étude moléculaire et comportementale de la variabilité de réponse à la cocaïne
Martinez, L. A. A. (2021) · theses.fr (ABES) · doi:10.70675/c394f299z9930z4d9fzb9ecz074185fe9fee
Arana-Lechuga, D. Y., Pérez-Morales, M., & Sánchez-Escandón, Ó. (2026) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-026-00325-5
“…such as cocaine and methylphenidate, inhibit DAT and then increase DA availability and enhance the associated reinforcing effects of DA [ 81], in a positron emission tomography study (PET), a single night of sleep deprivation decreases D 2 /D 3 receptor availability in the ventral…”
Dopaminergic Impact on External Brain Stimulation-Induced Neuroplasticity in Human Motor Cortex
Monte-Silva, K. K. (2009) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3275
Volkow (1999) · doi:10.1002/(sici)1098-2396(199901)31:1<59::aid-syn8>3.0.co;2-y
Self-citation
Metadata
- Authors
- Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Schlyer, D., Hitzemann, R., Lieberman, J., Angrist, B., Pappas, N., MacGregor, R., Burr, G., Cooper, T., & Wolf, A. P.
- Affiliations
- State University of New York (US)
- Brookhaven National Laboratory (US)
- Zucker Hillside Hospital (US)
- New York University (US)
- Northport VA Medical Center (US)
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 1994-04
- Volume
- 16
- Issue
- 4
- Pages
- 255-262
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W2006715508
- Cited by
- 379
- References
- 68
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 10 · 2020: 5 · 2019: 8 · 2018: 2 · 2017: 9 · 2016: 6 · 2015: 13 · 2014: 16 · 2013: 12 · 2012: 12
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Synapse (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Energy
- National Institutes of Health (5p01ns015638-15)
- National Institute on Drug Abuse (NIDA 5RO1-DA06891, R01DA006891)
- National Institute of Neurological Disorders and Stroke (NINDS NS15638)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- endogenous dopamine, dopamine release, [11C]raclopride, dopamine D2 receptor, striatal dopamine, psychostimulants, age-related changes, mood, anxiety
- MeSH terms
- Adult, Affect, Anxiety, Basal Ganglia, Binding, Competitive, Brain, Brain Chemistry, Cerebrovascular Circulation, Dopamine, Humans, Male, Methylphenidate, Middle Aged, Salicylamides, Synapses, Tomography, Emission-Computed, Neostriatum, Raclopride, Dopamine D2 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.